Evidence map›Paper›PMID 33152252›Full record

ArticleAmerican journal of respiratory and critical care medicine2021

Alteration of the Renin-Angiotensin-Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3.

Adrien Picod, Benjamin Deniau, Prabakar Vaittinada Ayar, Magali Genest, Nathan Julian, Feriel Azibani, Alexandre Mebazaa

Registry-linked trialAbstract readLetterComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05824767 (DPP3, Angiotensin II, and Renin Kinetics in Sepsis), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05824767 phase4completednot on this mapstarted 2023, after this paper: background citation

DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) Pilot: Serum Biomarkers to Predict Response to Angiotensin II vs. Standard-of-care Vasopressor Therapy in the Treatment of Septic Shock, a Randomized Controlled Pilot Trial

TypeinterventionalSponsorUniversity of New MexicoRan2023 to 2025Enrolled42ConditionsSeptic Shock, Vasodilatory ShockArmsAngiotensin II
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II.Journal of burn care & research : official publication of the American Burn Association · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Angiotensin 1-7 in an experimental septic shock model.Critical care (London, England) · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Adrien PicodINSERM U942 MASCOT Paris, France and.ORCID 0000-0002-0639-5598
Benjamin DeniauINSERM U942 MASCOT Paris, France and.
Prabakar Vaittinada AyarINSERM U942 MASCOT Paris, France and.
Magali GenestINSERM U942 MASCOT Paris, France and.
Nathan JulianINSERM U942 MASCOT Paris, France and.
Feriel AzibaniINSERM U942 MASCOT Paris, France and.
Alexandre MebazaaINSERM U942 MASCOT Paris, France and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin IIReninCatecholaminesDipeptidyl-Peptidases and Tripeptidyl-PeptidasesHumansRenin-Angiotensin SystemAngiotensin IICatecholaminesDipeptidyl-Peptidases and Tripeptidyl-PeptidasesRenin

Identifiers

PMID33152252
PMCPMC7885828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.